메뉴 건너뛰기




Volumn 12, Issue , 2012, Pages

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin

Author keywords

C peptide; Diabetes; Glucose; Insulin; Postprandial

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

EID: 84861935779     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-6     Document Type: Article
Times cited : (15)

References (32)
  • 2
    • 84864376161 scopus 로고    scopus 로고
    • National Institute of Clinical Excellence (UK)
    • National Institute of Clinical Excellence (UK) Guideline CG15, Type 1 diabetes in adults 2004, National Institute of Clinical Excellence (UK).
    • (2004) Guideline CG15, Type 1 diabetes in adults
  • 3
    • 0037737732 scopus 로고    scopus 로고
    • Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review
    • 10.1001/jama.289.17.2254, 12734137
    • DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003, 289:2254-2264. 10.1001/jama.289.17.2254, 12734137.
    • (2003) JAMA , vol.289 , pp. 2254-2264
    • DeWitt, D.E.1    Hirsch, I.B.2
  • 4
    • 0032055459 scopus 로고    scopus 로고
    • Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998, 128:517-523. The Diabetes Control and Complications Trial Research Group.
    • (1998) Ann Intern Med , vol.128 , pp. 517-523
  • 5
    • 0034853485 scopus 로고    scopus 로고
    • Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes
    • 10.1210/jc.86.9.4047, 11549624
    • Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001, 86:4047-4058. 10.1210/jc.86.9.4047, 11549624.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 4047-4058
    • Kahn, S.E.1
  • 6
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group
    • 10.1001/jama.281.21.2005, 10359389
    • Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999, 281:2005-2012. 10.1001/jama.281.21.2005, 10359389.
    • (1999) JAMA , vol.281 , pp. 2005-2012
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3    Holman, R.R.4
  • 7
    • 0020415397 scopus 로고
    • C-peptide reactivity as a measure of insulin dependency in obese diabetic patients treated with insulin
    • 10.2337/diacare.5.6.585, 6765512
    • Hoekstra JB, Van Rijn HJ, Thijssen JH, Erkelens DW. C-peptide reactivity as a measure of insulin dependency in obese diabetic patients treated with insulin. Diabetes Care 1982, 5:585-591. 10.2337/diacare.5.6.585, 6765512.
    • (1982) Diabetes Care , vol.5 , pp. 585-591
    • Hoekstra, J.B.1    Van Rijn, H.J.2    Thijssen, J.H.3    Erkelens, D.W.4
  • 8
    • 65449181587 scopus 로고    scopus 로고
    • Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study
    • 10.1111/j.1463-1326.2008.00975.x, 19422402
    • Hohberg C, Pfutzner A, Forst T, Lubben G, Karagiannis E, Borchert M, Schondorf T. Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual beta-cell function: results from the PioSwitch study. Diabetes Obes Metab 2009, 11:464-471. 10.1111/j.1463-1326.2008.00975.x, 19422402.
    • (2009) Diabetes Obes Metab , vol.11 , pp. 464-471
    • Hohberg, C.1    Pfutzner, A.2    Forst, T.3    Lubben, G.4    Karagiannis, E.5    Borchert, M.6    Schondorf, T.7
  • 9
    • 0028034406 scopus 로고
    • Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination
    • 10.1111/j.1464-5491.1994.tb00253.x, 7895460
    • Hermann LS, Schersten B, Melander A. Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination. Diabet Med 1994, 11:953-960. 10.1111/j.1464-5491.1994.tb00253.x, 7895460.
    • (1994) Diabet Med , vol.11 , pp. 953-960
    • Hermann, L.S.1    Schersten, B.2    Melander, A.3
  • 10
    • 0004420267 scopus 로고    scopus 로고
    • Classification of type 2 diabetes by clinical response to metformin-troglitazone combination and C-Peptide criteria
    • Lee A, Morley J. Classification of type 2 diabetes by clinical response to metformin-troglitazone combination and C-Peptide criteria. Endocr Pract 1999, 5:305-313.
    • (1999) Endocr Pract , vol.5 , pp. 305-313
    • Lee, A.1    Morley, J.2
  • 11
    • 0021687504 scopus 로고
    • Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy
    • 10.1111/j.1464-5491.1984.tb01974.x, 6242818
    • Grant PJ, Barlow E, Miles DW. Plasma C-peptide levels identify insulin-treated diabetic patients suitable for oral hypoglycaemic therapy. Diabet Med 1984, 1:284-286. 10.1111/j.1464-5491.1984.tb01974.x, 6242818.
    • (1984) Diabet Med , vol.1 , pp. 284-286
    • Grant, P.J.1    Barlow, E.2    Miles, D.W.3
  • 12
    • 0019506637 scopus 로고
    • Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus
    • Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transbol I, Binder C. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981, 210:153-156.
    • (1981) Acta Med Scand , vol.210 , pp. 153-156
    • Madsbad, S.1    Krarup, T.2    McNair, P.3    Christiansen, C.4    Faber, O.K.5    Transbol, I.6    Binder, C.7
  • 13
    • 63049094584 scopus 로고    scopus 로고
    • Use of serum c-peptide level to simplify diabetes treatment regimens in older adults
    • 10.1016/j.amjmed.2008.12.008, 19332236
    • Munshi MN, Hayes M, Sternthal A, Ayres D. Use of serum c-peptide level to simplify diabetes treatment regimens in older adults. Am J Med 2009, 122:395-397. 10.1016/j.amjmed.2008.12.008, 19332236.
    • (2009) Am J Med , vol.122 , pp. 395-397
    • Munshi, M.N.1    Hayes, M.2    Sternthal, A.3    Ayres, D.4
  • 14
    • 0023949595 scopus 로고
    • Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins
    • Laakso M, Sarlund H, Korhonen T, Voutilainen E, Majander H, Hakala P, Uusitupa M, Pyorala K. Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins. Acta Med Scand 1988, 223:61-68.
    • (1988) Acta Med Scand , vol.223 , pp. 61-68
    • Laakso, M.1    Sarlund, H.2    Korhonen, T.3    Voutilainen, E.4    Majander, H.5    Hakala, P.6    Uusitupa, M.7    Pyorala, K.8
  • 15
    • 0031014837 scopus 로고    scopus 로고
    • Characteristics related to poor glycemic control in NIDDM patients in community practice
    • 10.2337/diacare.20.1.7, 9028685
    • Blaum CS, Velez L, Hiss RG, Halter JB. Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 1997, 20:7-11. 10.2337/diacare.20.1.7, 9028685.
    • (1997) Diabetes Care , vol.20 , pp. 7-11
    • Blaum, C.S.1    Velez, L.2    Hiss, R.G.3    Halter, J.B.4
  • 16
    • 0034010240 scopus 로고    scopus 로고
    • Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education
    • 10.1093/qjmed/93.3.183, 10751238
    • Chan WB, Chan JC, Chow CC, Yeung VT, So WY, Li JK, Ko GT, Ma RC, Cockram CS. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education. QJM 2000, 93:183-190. 10.1093/qjmed/93.3.183, 10751238.
    • (2000) QJM , vol.93 , pp. 183-190
    • Chan, W.B.1    Chan, J.C.2    Chow, C.C.3    Yeung, V.T.4    So, W.Y.5    Li, J.K.6    Ko, G.T.7    Ma, R.C.8    Cockram, C.S.9
  • 17
    • 0022975137 scopus 로고
    • Plasma and urinary C-peptide in the classification of adult diabetics
    • 10.3109/00365518609083728, 3538365
    • Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppala P. Plasma and urinary C-peptide in the classification of adult diabetics. Scand J Clin Lab Invest 1986, 46:655-663. 10.3109/00365518609083728, 3538365.
    • (1986) Scand J Clin Lab Invest , vol.46 , pp. 655-663
    • Koskinen, P.1    Viikari, J.2    Irjala, K.3    Kaihola, H.L.4    Seppala, P.5
  • 18
    • 0023761266 scopus 로고
    • Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables
    • 10.2337/diacare.11.7.531, 3203569
    • Hother-Nielsen O, Faber O, Sorensen NS, Beck-Nielsen H. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 1988, 11:531-537. 10.2337/diacare.11.7.531, 3203569.
    • (1988) Diabetes Care , vol.11 , pp. 531-537
    • Hother-Nielsen, O.1    Faber, O.2    Sorensen, N.S.3    Beck-Nielsen, H.4
  • 19
    • 79955781269 scopus 로고    scopus 로고
    • Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes
    • 10.1507/endocrj.K10E-399, 21415555
    • Saisho Y, Kou K, Tanaka K, Abe T, Kurosawa H, Shimada A, Meguro S, Kawai T, Itoh H. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes. Endocr J 2011, 58:315-322. 10.1507/endocrj.K10E-399, 21415555.
    • (2011) Endocr J , vol.58 , pp. 315-322
    • Saisho, Y.1    Kou, K.2    Tanaka, K.3    Abe, T.4    Kurosawa, H.5    Shimada, A.6    Meguro, S.7    Kawai, T.8    Itoh, H.9
  • 20
    • 0032822322 scopus 로고    scopus 로고
    • Assays for insulin, proinsulin(s) and C-peptide
    • Clark PM. Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Biochem 1999, 36(Pt 5):541-564.
    • (1999) Ann Clin Biochem , vol.36 , Issue.PART 5 , pp. 541-564
    • Clark, P.M.1
  • 21
    • 55249085210 scopus 로고    scopus 로고
    • Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes
    • 10.2337/dc07-2451, 2551636, 18628574
    • Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008, 31:1966-1971. 10.2337/dc07-2451, 2551636, 18628574.
    • (2008) Diabetes Care , vol.31 , pp. 1966-1971
    • Greenbaum, C.J.1    Mandrup-Poulsen, T.2    McGee, P.F.3    Battelino, T.4    Haastert, B.5    Ludvigsson, J.6    Pozzilli, P.7    Lachin, J.M.8    Kolb, H.9
  • 22
    • 0034819464 scopus 로고    scopus 로고
    • Combination therapies with insulin in type 2 diabetes
    • 10.2337/diacare.24.4.758, 11315844
    • Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001, 24:758-767. 10.2337/diacare.24.4.758, 11315844.
    • (2001) Diabetes Care , vol.24 , pp. 758-767
    • Yki-Jarvinen, H.1
  • 24
    • 80051660576 scopus 로고    scopus 로고
    • Urine C-peptide creatinine ratio (UCPCR) is an alternative to stimulated serum C-peptide measurement in late onset insulin treated diabetes
    • 10.1111/j.1464-5491.2011.03272.x, 21843301
    • Jones AG, Besser REJ, McDonald TJ, Shields BM, Hope SV, Bowman P, Oram RA, Knight BA, Hattersley AT. Urine C-peptide creatinine ratio (UCPCR) is an alternative to stimulated serum C-peptide measurement in late onset insulin treated diabetes. Diabet Med 2011, 28(9):1034-1038. 10.1111/j.1464-5491.2011.03272.x, 21843301.
    • (2011) Diabet Med , vol.28 , Issue.9 , pp. 1034-1038
    • Jones, A.G.1    Besser, R.E.J.2    McDonald, T.J.3    Shields, B.M.4    Hope, S.V.5    Bowman, P.6    Oram, R.A.7    Knight, B.A.8    Hattersley, A.T.9
  • 25
    • 79956067719 scopus 로고    scopus 로고
    • Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes
    • 10.2337/dc10-2114, 3041191, 21285386
    • Besser RE, Ludvigsson J, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes. Diabetes Care 2011, 34(3):607-609. 10.2337/dc10-2114, 3041191, 21285386.
    • (2011) Diabetes Care , vol.34 , Issue.3 , pp. 607-609
    • Besser, R.E.1    Ludvigsson, J.2    Jones, A.G.3    McDonald, T.J.4    Shields, B.M.5    Knight, B.A.6    Hattersley, A.T.7
  • 26
    • 70449698272 scopus 로고    scopus 로고
    • Stability and reproducibility of a single-sample urinary C-Peptide/Creatinine ratio and its correlation with 24-h Urinary C-Peptide
    • 10.1373/clinchem.2009.129312, 19713273
    • McDonald TJ, Knight BA, Shields BM, Bowman P, Salzmann MB, Hattersley AT. Stability and reproducibility of a single-sample urinary C-Peptide/Creatinine ratio and its correlation with 24-h Urinary C-Peptide. Clin Chem 2009, 55(11):2035-2039. 10.1373/clinchem.2009.129312, 19713273.
    • (2009) Clin Chem , vol.55 , Issue.11 , pp. 2035-2039
    • McDonald, T.J.1    Knight, B.A.2    Shields, B.M.3    Bowman, P.4    Salzmann, M.B.5    Hattersley, A.T.6
  • 27
    • 12244299450 scopus 로고    scopus 로고
    • Beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis
    • Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005, 90:493-500.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 493-500
    • Ferrannini, E.1    Gastaldelli, A.2    Miyazaki, Y.3    Matsuda, M.4    Mari, A.5    DeFronzo, R.A.6
  • 28
    • 66549089200 scopus 로고    scopus 로고
    • Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents
    • 10.2337/dc08-1956, 2681045, 19244086
    • Kohnert KD, Augstein P, Zander E, Heinke P, Peterson K, Freyse EJ, Hovorka R, Salzsieder E. Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 2009, 32:1058-1062. 10.2337/dc08-1956, 2681045, 19244086.
    • (2009) Diabetes Care , vol.32 , pp. 1058-1062
    • Kohnert, K.D.1    Augstein, P.2    Zander, E.3    Heinke, P.4    Peterson, K.5    Freyse, E.J.6    Hovorka, R.7    Salzsieder, E.8
  • 30
    • 73249122485 scopus 로고    scopus 로고
    • Latent autoimmune diabetes in adults
    • 10.1210/jc.2009-1120, 19837918
    • Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab 2009, 94:4635-4644. 10.1210/jc.2009-1120, 19837918.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 4635-4644
    • Naik, R.G.1    Brooks-Worrell, B.M.2    Palmer, J.P.3
  • 31
    • 75549090118 scopus 로고    scopus 로고
    • Defining and characterizing the progression of type 2 diabetes
    • 2811457, 19875543
    • Fonseca VA. Defining and characterizing the progression of type 2 diabetes. Diabetes Care 2009, 32(Suppl 2):S151-S156. 2811457, 19875543.
    • (2009) Diabetes Care , vol.32 , Issue.SUPPL. 2
    • Fonseca, V.A.1
  • 32
    • 75549087108 scopus 로고    scopus 로고
    • Insulin therapy for type 2 diabetes
    • 2811456, 19875560
    • Swinnen SG, Hoekstra JB, DeVries JH. Insulin therapy for type 2 diabetes. Diabetes Care 2009, 32(Suppl 2):S253-S259. 2811456, 19875560.
    • (2009) Diabetes Care , vol.32 , Issue.SUPPL. 2
    • Swinnen, S.G.1    Hoekstra, J.B.2    DeVries, J.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.